Antibiotic susceptibility of coagulase-negativestaphylococci (CoNS): Emergence of teicoplaninnon-susceptible CoNS strains with inducible resistance to vancomycin

Journal of Medical Microbiology

Volumn 60, Issue 11, 2011, Pages 1661-1668

  Ma, Xiao Xue ^a   Wang, En Hua ^a   Liu, Yong ^a   Luo, En Jie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CHLORAMPHENICOL; CILASTATIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; OXACILLIN; PENICILLIN G; PIPERACILLIN; RIFAMPICIN; TAZOBACTAM; TEICOMYCIN; TEICOPLANIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BIOSURVEILLANCE; CHINA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS CAPRAE; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS WARNERI;

ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; CHINA; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, AGAR GEL; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TEICOPLANIN; VANCOMYCIN;

EID: 80054733587     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.034066-0     Document Type: Article

References (27)

1. Bourgeois, I., Pestel-Caron, M., Lemeland, J. F., Pons, J. L. & Caron, F. (2007). Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci. Antimicrob Agents Chemother 51, 740-743.
2. Boyce, J. M. (2004). Coagulase-negative staphylococci. In Hospital Epidemiology and Infection Control, 3rd edn, pp. 495-516. Edited by C. G. Mayhall. Philadelphia, PA: Lippincott Williams & Wilkins.
3. Casey, A. L., Lambert, P. A. & Elliott, T. S. J. (2007). Staphylococci. Int J Antimicrob Agents 29 (Suppl. 3), S23-S32.
4. Cervera, C., Almela, M., Martínez-Martínez, J. A., Moreno, A. & Miró, J. M. (2009). Risk factors and management of Gram-positive bacteraemia. Int J Antimicrob Agents 34 (Suppl. 4), S26-S30.
5. CLSI (2010). Performance Standards for Antimicrobial Susceptibility Testing, 19th Informational Supplement, M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Cremniter, J., Slassi, A., Quincampoix, J. C., Sivadon-Tardy, V., Bauer, T., Porcher, R., Lortat-Jacob, A., Piriou, P., Judet, T. & other authors (2010). Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative staphylococci isolated from orthopedicdevice-associated infections. J Clin Microbiol 48, 1428-1431.
7. Dubois, D., Leyssene, D., Chacornac, J. P., Kostrzewa, M., Schmit, P. O., Talon, R., Bonnet, R. & Delmas, J. (2010). Identification of a variety of Staphylococcus species by matrix-assisted laser desorption ionization time of flight mass spectrometry. J Clin Microbiol 48, 941-945.
8. Ferreira, R. B., Iorio, N. L., Malvar, K. L., Nunes, A. P., Fonseca, L. S., Bastos, C. C. & Santos, K. R. (2003). Coagulase-negative staphylococci: comparison of phenotypic and genotypic oxacillin susceptibility tests and evaluation of the agar screening test by using different concentrations of oxacillin. J Clin Microbiol 41, 3609-3614.
9. Gazzola, S. & Cocconcelli, P. S. (2008). Vancomycin heteroresistance and biofilm formation in Staphylococcus epidermidis from food. Microbiology 154, 3224-3231.
10. Huebner, J. & Goldmann, D. A. (1999). Coagulase-negative staphylococci: role as pathogens. Annu Rev Med 50, 223-236.
11. Hung, K. H., Yan, J. J., Lu, Y. C., Chen, H. M. & Wu, J. J. (2011). Evaluation of discrepancies between oxacillin and cefoxitin susceptibility in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 30, 785-788.
12. Kristóf, K., Kocsis, E., Szabó, D., Kardos, S., Cser, V., Nagy, K., Hermann, P. & Rozgonyi, F. (2011). Significance of methicillinteicoplanin resistant Staphylococcus haemolyticus in bloodstream infections in patients of the Semmelweis University hospitals in Hungary. Eur J Clin Microbiol Infect Dis 30, 691-699.
13. Lorenzo-Díaz, F., Delgado, T., Reyes-Darias, J. A., Flores, C., Méndez-Alvarez, S., Villar, J., Sierra, A. & Claverie-Martín, F. (2004). Characterization of the first VanB vancomycin-resistant Enterococcus faecium isolated in a Spanish hospital. Curr Microbiol 48, 199-203.
14. Ma, X. X., Sun, D. D., Hu, J., Wang, E. H. & Luo, E. J. (2011). Epidemiological and molecular characterization of Staphylococcus haemolyticus strains, from a hematology ward, with decreased susceptibility to glycopeptides. Can J Microbiol 57, 476-484.
15. Maniati, M., Petinaki, E., Spiliopoulou, I., Kontos, Petropoulou Mylona, D. (2005) Rapid increase in numbers of Staphylococcus epidermidis strains with reduced susceptibility to teicoplanin in Greece Int J Antimicrob Agents 25, 346-348.
16. Matsuhashi, M., Song, M. D., Ishino, F., Wachi, M., Doi, M., Inoue, M., Ubukata, K., Yamashita, N. & Konno, M. (1986). Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to b-lactam antibiotics in Staphylococcus aureus. J Bacteriol 167, 975-980.
17. Natoli, S., Fontana, C., Favaro, M., Bergamini, A., Testore, G. P., Minelli, S., Bossa, M. C., Casapulla, M., Broglio, G. & other authors (2009). Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options. BMC Infect Dis 9, 83.
18. Otto, M. (2009). Staphylococcus epidermidis the 'accidental' pathogen. Nat Rev Microbiol 7, 555-567.
19. Palazzo, I. C., Araujo, M. L. & Darini, A. L. (2005). First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil. J Clin Microbiol 43, 179-185.
20. Périchon, B. & Courvalin, P. (2009). VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53, 4580-4587.
21. Sieradzki, K., Villari, P. & Tomasz, A. (1998). Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother 42, 100-107.
22. Srinivasan, A., Dick, J. D. & Perl, T. M. (2002). Vancomycin resistance in staphylococci. Clin Microbiol Rev 15, 430-438.
23. Stefani, S. & Varaldo, P. E. (2003). Epidemiology of methicillinresistant staphylococci in Europe. Clin Microbiol Infect 9, 1179-1186.
24. Tacconelli, E., Tumbarello, M., Donati, K. G., Bettio, M., Spanu, T., Leone, F., Sechi, L. A., Zanetti, S., Fadda, G. & Cauda, R. (2001). Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a casecontrol study. Clin Infect Dis 33, 1628-1635.
25. Trueba, F., Garrabe, E., Hadef, R., Fabre, R., Cavallo, J. D., Tsvetkova, K., Chesneau, O. (2006). High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study. J Clin Microbiol 44, 1922-1923.
26. Tschudin Sutter, S., Frei, R., Dangel, M., Gratwohl, A., Bonten, M. & Widmer, A. F. (2010). Not all patients with vancomycinresistant enterococci need to be isolated. Clin Infect Dis 51, 678-683.
27. Zong, Z. Y., Peng, C. H. & Lu, X. J. (2011). Diversity of SCCmec elements in methicillin-resistant coagulase-negative staphylococci clinical isolates. PLoS One 6, e20191.